enGene Holdings Inc. (ENGN) earnings
ENGN earnings moved a median of +1.14% by the close. Quarterly and annual ENGN reports and results, each read against the price at its own news timestamp. Back to the ENGN overview →
22 measured ENGN earnings events.
Where these ENGN earnings landedvs 22 measured ENGN earnings reactions
| Middle 50% of ENGN earnings reactions | -5.27% to +3.85% |
|---|---|
| Median reaction (to close) | +1.14% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 ENGN earnings events with a measured close landed between -5.27% and +3.85%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| enGene Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | -1.65% | +5.50% | |
| Form 10-Q enGene Therapeutics Inc. For: Jul 31 | SEC filing · Form 10-Q | -1.65% | +5.50% | |
| enGene Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +3.71% | +1.14% | |
| Form 10-Q enGene Therapeutics Inc. For: Apr 30 | SEC filing · Form 10-Q | +3.71% | +1.14% | |
| enGene Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -1.49% | -12.53% | |
| Form 10-Q enGene Holdings Inc. For: Jan 31 | SEC filing · Form 10-Q | -1.49% | -12.53% | |
| Form 10-K/A enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | -2.40% | -0.67% | |
| Form 10-K enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | +3.31% | +5.13% | |
| enGene Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +3.46% | -5.78% | |
| enGene Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +5.00% | +1.56% | |
| Form 10-Q enGene Holdings Inc. For: Apr 30 | SEC filing · Form 10-Q | +5.00% | +1.56% | |
| enGene Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -3.83% | -3.74% | |
| Form 10-Q enGene Holdings Inc. For: Jan 31 | SEC filing · Form 10-Q | -3.83% | -3.74% | |
| Form 10-K/A enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | +0.40% | +1.13% | |
| Form 10-K enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | -3.67% | -10.86% | |
| enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update | Press release | +4.13% | +4.36% | |
| Form 10-Q enGene Holdings Inc. For: Jul 31 | SEC filing · Form 10-Q | +4.13% | +4.36% | |
| enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update | Press release | -9.55% | -14.85% | |
| Form 10-Q enGene Holdings Inc. For: Apr 30 | SEC filing · Form 10-Q | -9.55% | -14.85% | |
| enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress | Press release | — | +2.32% | |
| Form 10-Q enGene Holdings Inc. For: Jan 31 | SEC filing · Form 10-Q | — | +2.32% | |
| Form 10-K enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | — | +4.72% |
Keep exploring
More ENGN: analyst actions → · SEC filings → · ENGN overview →